ProShare Advisors
LCTX icon

ProShare Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,865
Closed -$17.6K 2135
2025
Q1
$17.6K Sell
38,865
-2,741
-7% -$1.24K ﹤0.01% 2045
2024
Q4
$20.9K Buy
41,606
+13,691
+49% +$6.88K ﹤0.01% 2254
2024
Q3
$25.3K Buy
27,915
+10,141
+57% +$9.18K ﹤0.01% 2032
2024
Q2
$17.7K Sell
17,774
-6,067
-25% -$6.05K ﹤0.01% 1813
2024
Q1
$35.3K Buy
23,841
+1,877
+9% +$2.78K ﹤0.01% 1947
2023
Q4
$23.9K Buy
21,964
+5,198
+31% +$5.67K ﹤0.01% 1912
2023
Q3
$19.8K Sell
16,766
-18
-0.1% -$21 ﹤0.01% 1788
2023
Q2
$23.7K Buy
+16,784
New +$23.7K ﹤0.01% 1829
2022
Q2
Sell
-23,513
Closed -$36K 1974
2022
Q1
$36K Sell
23,513
-3,884
-14% -$5.95K ﹤0.01% 2138
2021
Q4
$67K Buy
27,397
+11,326
+70% +$27.7K ﹤0.01% 2249
2021
Q3
$40K Sell
16,071
-15,388
-49% -$38.3K ﹤0.01% 1973
2021
Q2
$90K Buy
+31,459
New +$90K ﹤0.01% 2306
2020
Q1
Sell
-14,661
Closed -$13K 1398
2019
Q4
$13K Buy
14,661
+2,343
+19% +$2.08K ﹤0.01% 1784
2019
Q3
$12K Buy
12,318
+359
+3% +$350 ﹤0.01% 1652
2019
Q2
$13K Sell
11,959
-314
-3% -$341 ﹤0.01% 1616
2019
Q1
$16K Buy
+12,273
New +$16K ﹤0.01% 1650
2018
Q4
Sell
-10,955
Closed -$26K 1641
2018
Q3
$26K Sell
10,955
-842
-7% -$2K ﹤0.01% 1749
2018
Q2
$24K Buy
11,797
+725
+7% +$1.48K ﹤0.01% 1785
2018
Q1
$30K Sell
11,072
-1,786
-14% -$4.84K ﹤0.01% 1698
2017
Q4
$28K Buy
+12,858
New +$28K ﹤0.01% 1787
2017
Q1
Sell
-11,171
Closed -$40K 1614
2016
Q4
$40K Buy
+11,171
New +$40K ﹤0.01% 1719
2015
Q2
Sell
-10,054
Closed -$50K 1722
2015
Q1
$50K Sell
10,054
-1,121
-10% -$5.58K ﹤0.01% 1869
2014
Q4
$42K Sell
11,175
-9,502
-46% -$35.7K ﹤0.01% 1926
2014
Q3
$65K Sell
20,677
-4,682
-18% -$14.7K ﹤0.01% 2229
2014
Q2
$77K Sell
25,359
-12,031
-32% -$36.5K ﹤0.01% 2408
2014
Q1
$123K Buy
+37,390
New +$123K ﹤0.01% 2651
2013
Q4
Sell
-23,328
Closed -$89K 1616
2013
Q3
$89K Buy
23,328
+1,310
+6% +$5K ﹤0.01% 2442
2013
Q2
$87K Buy
+22,018
New +$87K ﹤0.01% 2285